Variant report
Variant | nsv433216 |
---|---|
Chromosome Location | chr3:83128414-83207518 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145280648 | chr3:83138709-83138710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs112266030 | chr3:83138739-83138740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs546963210 | chr3:83138741-83138742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs570058925 | chr3:83138750-83138751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs398082242 | chr3:83138751-83138752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs57953557 | chr3:83138752-83138753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573232857 | chr3:83138787-83138788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs566573440 | chr3:83138790-83138791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs535320592 | chr3:83138839-83138840 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555253579 | chr3:83138910-83138911 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191989520 | chr3:83138931-83138932 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs546422034 | chr3:83138946-83138947 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs557700561 | chr3:83138996-83138997 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs149541921 | chr3:83139019-83139020 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540000240 | chr3:83139023-83139024 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs117812600 | chr3:83139044-83139045 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs573687101 | chr3:83139105-83139106 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs376145856 | chr3:83139181-83139182 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs144001493 | chr3:83139203-83139204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs532510826 | chr3:83139226-83139227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs531260240 | chr3:83139246-83139247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551138657 | chr3:83139349-83139350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564565085 | chr3:83139365-83139366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs533466148 | chr3:83139390-83139391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546783873 | chr3:83139436-83139437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566490084 | chr3:83139444-83139445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs182666039 | chr3:83139505-83139506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548991397 | chr3:83139509-83139510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs62262717 | chr3:83139513-83139514 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs537789436 | chr3:83139522-83139523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs186039290 | chr3:83139563-83139564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs561934994 | chr3:83139578-83139579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs115665529 | chr3:83139581-83139582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs573998072 | chr3:83139600-83139601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs74282385 | chr3:83139610-83139611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs148249349 | chr3:83139625-83139626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs542624602 | chr3:83139683-83139684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs532881752 | chr3:83139704-83139705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs7632969 | chr3:83139725-83139726 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs575999690 | chr3:83139739-83139740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs189823327 | chr3:83139788-83139789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs10212514 | chr3:83139825-83139826 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs141868838 | chr3:83139843-83139844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs182465430 | chr3:83139862-83139863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs570121518 | chr3:83139908-83139909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs187159531 | chr3:83139928-83139929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs540689172 | chr3:83139969-83139970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs147271794 | chr3:83140006-83140007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs533745942 | chr3:83140030-83140031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs546920049 | chr3:83140150-83140151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Autism | 20808228 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Medulloblastoma | 16783165 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:83138600-83138800 | Weak transcription | Pancreas | Pancrea |
2 | chr3:83138800-83139200 | Genic enhancers | Pancreas | Pancrea |
3 | chr3:83139200-83142000 | Weak transcription | Pancreas | Pancrea |
4 | chr3:83140800-83142200 | Enhancers | Liver | Liver |
5 | chr3:83141600-83142600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr3:83142200-83142600 | Flanking Active TSS | Liver | Liver |
7 | chr3:83142200-83143200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
8 | chr3:83142600-83142800 | Enhancers | Liver | Liver |
9 | chr3:83145600-83145800 | Enhancers | Pancreas | Pancrea |
10 | chr3:83163000-83163200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr3:83163200-83164200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
12 | chr3:83164200-83165400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
13 | chr3:83193600-83194200 | Enhancers | Dnd41 | blood |
14 | chr3:83200000-83200400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |